BCL2 and in situ carcinoma: Compared to the Smyd2fl/fl + CIS group, the Smyd2tecKO + CIS group exhibited significantly lower protein levels of BAX and cleaved caspase‐3, alongside upregulated Bcl‐2 and caspase‐3 levels (Figure 5C,D).